Medical Xpress reported on 19 October that an international clinical trial published in JAMA Network Open found that people with major depression could use a non-invasive brain-stimulation system at home. The study focused on feasibility and safety, while noting that further work is needed to understand what drives symptom improvement.

Medical Xpress reported on 19 October that University of Queensland researchers found a new model for genetic testing in children with immune conditions could reduce waiting times from as long as 12 months to around two weeks in appropriate cases. In the study, treatment plans changed after diagnosis in 90% of cases.

Reuters and the Associated Press reported on 19 October that the United States announced a new Women's Health Division within the National Institutes of Health and a White House Women's Health Task Force. The initiative aims to improve research, diagnosis and treatment for conditions that uniquely or disproportionately affect women.

Medical Xpress reported on 19 October that researchers identified Miro1 as a possible contributor to insulin resistance in skeletal muscle. In preclinical models, removing the protein restored aspects of insulin responsiveness, while exercise was associated with lower muscle Miro1 levels in people with type 2 diabetes.

Medical Xpress reported on 20 October that a new PET imaging approach detected 97.9% of lesions in clear-cell renal cell carcinoma, a common form of kidney cancer. Better lesion detection could help clinicians assess the location and extent of disease.

Medical Xpress reported on 20 October that a research team led by IMDEA Materials Institute and the Universidad Politécnica de Madrid developed a 3D-printing method for manufacturing personalized cardiovascular medical devices. The technology could support more patient-specific device designs.